Big Biotec Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -99.37%
- Profit Growth -1359.81%
- Ebitda 67.75%
- Net Worth -11.97%
- Total Assets -30.96%
About Big Biotec
Big Biotec Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2012 and has a history of 12 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vicky Kumar and Aakash Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33110DL2012PTC231781
-
Company No.
231781
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Big Biotec Private Limited offer?
Big Biotec Private Limited offers a wide range of products and services, including Filling Machines & Plants, Volumetric Filling Machine.
Who are the key members and board of directors at Big Biotec?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vicky Kumar
|
Director | 21-Feb-2012 | Current |
|
Aakash Kumar
|
Director | 21-Jul-2015 | Current |
Financial Performance of Big Biotec.
Big Biotec Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.37% decrease. The company also saw a substantial fall in profitability, with a 1359.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Big Biotec?
In 2021, Big Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tyykem Private LimitedVicky Kumar and Aakash Kumar are mutual person
-
Ubhagen Wellness Systems Private LimitedVicky Kumar and Aakash Kumar are mutual person
-
Pharmsun Private Limited
Vicky Kumar and Aakash Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Big Biotec?
Unlock and access historical data on people associated with Big Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Big Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Big Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
